Gapping up
In reaction to strong earnings/guidance: GIGA +13.2%, UNFI +10.7%, VNCE+5.4%, NAV +2%, XTLY +1%, HDS +0.8%, THO +0.6%
M&A news: LDRH +63.6% (to be acquired by Zimmer Biomet Holdings (ZBH) for $37.00/share in cash), AXLL +6% (Lotte Chemical submits bid to acquire Axiall for more than $2.6 bln, according to reports)
Select financial related names showing strength: DB +2.3%, SAN +2%, ING+1.5%, BCS +1.5%, MS +1%
Select oil/gas related names showing strength: CHK +3.3%, WLL +3.2%,SDRL +2.9%, TOT +2.2%, BP +1.2%
Other news: SRPT +31.5% (discloses FDA request that Co provide dystrophin data from biopsies already obtained from the ongoing confirmatory study of eteplirsen), DCTH +21.2% (enters into security purchase agreement with an institutional investor to issue $35 mln in senior convertible notes & related common stock purchase warrants), WGBS +13.5% (enters into an exclusive distribution agreement in Japan with Takara Bio), CTIC +12.3% (presents LT follow up data for Pacritinib showing reductions in spleen volume and symptom burden), Z +10.5% (settlement agreement with News Corp), ZG+9.7% (settlement agreement with News Corp), AEHR +7.5% (announces over $4.5 mln in orders of its FOX-XP production test cell; revs from these sales are expected to continue through early 2017), RGLS +5.4% (announces top-line results from the primary endpoint analysis of one of the company's ongoing phase II studies of RG-101 for the treatment of hepatitis C virus infection), IBN +3.4% (reports of additional funding received), RDS.A +3.4% (hosts Capital Markets Day; sees better than expected synergies from BG acquisition)
Analyst comments: MRO +3.1% (initiated with a Buy at KLR Group), WDC+1.7% (upgraded to Buy from Neutral at Mizuho), CCL +1.4% (initiated with a Buy at Sterne Agee CRT)
In reaction to strong earnings/guidance: GIGA +13.2%, UNFI +10.7%, VNCE+5.4%, NAV +2%, XTLY +1%, HDS +0.8%, THO +0.6%
M&A news: LDRH +63.6% (to be acquired by Zimmer Biomet Holdings (ZBH) for $37.00/share in cash), AXLL +6% (Lotte Chemical submits bid to acquire Axiall for more than $2.6 bln, according to reports)
Select financial related names showing strength: DB +2.3%, SAN +2%, ING+1.5%, BCS +1.5%, MS +1%
Select oil/gas related names showing strength: CHK +3.3%, WLL +3.2%,SDRL +2.9%, TOT +2.2%, BP +1.2%
Other news: SRPT +31.5% (discloses FDA request that Co provide dystrophin data from biopsies already obtained from the ongoing confirmatory study of eteplirsen), DCTH +21.2% (enters into security purchase agreement with an institutional investor to issue $35 mln in senior convertible notes & related common stock purchase warrants), WGBS +13.5% (enters into an exclusive distribution agreement in Japan with Takara Bio), CTIC +12.3% (presents LT follow up data for Pacritinib showing reductions in spleen volume and symptom burden), Z +10.5% (settlement agreement with News Corp), ZG+9.7% (settlement agreement with News Corp), AEHR +7.5% (announces over $4.5 mln in orders of its FOX-XP production test cell; revs from these sales are expected to continue through early 2017), RGLS +5.4% (announces top-line results from the primary endpoint analysis of one of the company's ongoing phase II studies of RG-101 for the treatment of hepatitis C virus infection), IBN +3.4% (reports of additional funding received), RDS.A +3.4% (hosts Capital Markets Day; sees better than expected synergies from BG acquisition)
Analyst comments: MRO +3.1% (initiated with a Buy at KLR Group), WDC+1.7% (upgraded to Buy from Neutral at Mizuho), CCL +1.4% (initiated with a Buy at Sterne Agee CRT)